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The Valuation Implications of Sales Growth in Start-up Ventures
Ilanit Gavious∗ and Dafna Schwartz∗∗

We examine whether and how investors' reliance on financial information is affected by the rate of sales growth of a
start-up venture. We find that investors discern between firms by the extent to which their products are adopted by the
market. For firms that failed to increase their sales since IPO, investors perceive financial data as not providing relevant
or predictive information for investment decision making. In contrast, investors seem to rely heavily on financial
information provided by firms presenting a continuous increase in sales. We suggest that investors may perceive firms
with a continuous increase (decrease) in sales as those that are (un)able to transfer through the technology adoption
lifecycle and make the transition from an early market dominated by a few visionary customers to a mainstream market.
Whereas prior studies relate changes in the value-relevance of financial statements to a firm's maturity, as measured on
the basis of time (firm age), our findings indicate that the main factor affecting value-relevance is a firm's degree of
market penetration.
Keywords: financial statements, market penetration, start-up, sales growth, technology adoption, value-relevance,
valuation implications, venture capital.
JEL classification: G1; L26; M13; M41

Introduction
During the past few decades, the number of young technology based firms raising funds
through IPO has grown considerably. Concomitantly, academicians as well as practitioners have
questioned the relevance of financial statement information to the valuation of these technologybased, fast growing firms (henceforth referred to as 'start-up' ventures/firms). Most notably, these
firms are characterized by a high intensity of intangible assets, such as knowledge assets and high
R&D expenditures. The present value of their growth opportunities accounts for a larger portion of
their market value than the value of assets-in-place (e.g., Brealey and Myers, 1996). In contrast to
assets-in-place which do not depend on further discretionary investment by the firm, growth
opportunities can be regarded as call options to purchase real assets where ultimate value depends
on further discretionary investment (Myers, 1977). This reflects the high risk that characterizes
start-up ventures. Another characteristic risk is a high market risk – the risk that firms will not
succeed in fulfilling their market expectations as expressed in their prospectuses, and will not
manage to reach mainstream markets.1 This risk is not accounted for by Generally Accepted
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Accounting Principles (GAAP), but is probably reflected in securities pricing. Additionally, the
large investments in R&D and other intangibles are generally immediately expensed in financial
statements according to. GAAP. Hence, reported earnings and book values are usually depressed,
often appearing to be of dubious relevance for securities pricing.
This study investigates the valuation implications of sales growth, or the extent of adoption
of a new technology, in the post-IPO venture capital (VC) subsector. The analysis is based upon
theoretical grounds as well as on empirical data drawn from the Israeli experience during the last
decade. Since the beginning of the 1990s, the number of young start-up ventures in Israel has grown
from approximately 300 in 1991 to over 3,000 to date. Furthermore, the number of VC funds during
the same period increased from just two to over one hundred (Avnimelech and Teubal, 2004 a, b).
Israel has been defined as 'the world's most vital place for entrepreneurship' (Haour, 2005). In
investigating the sales record of each Israeli start-up firm that went IPO in NASDAQ during the
1990s, we identify two major groups of firms: (1) firms presenting a continuous growth in sales
since IPO, and (2) firms presenting either stagnation or a continuous reduction in sales since IPO.
We investigate whether and how a firm's growth in sales versus non-growth in sales affects
investors' reliance on its financial statements. Notably, the results of the analyses are robust to
partitioning the sample on alternative proxies of growth.
Continuously growing firms, in effect, convert future growth options into assets-in-place.
According to Hand (2005, p.614), 'Assuming that a maturing firm converts its existing investment
options into assets-in-place faster than it discovers new ones, then its financial statements will
reflect greater and greater fractions of its total equity value. Hence…its financial statements will
become increasingly associated with its equity value'. We predict that financial statements of firms
appearing to consistently increase (decrease) their sales are more (less) value-relevant.
The findings of the current study support our prediction. Investors seem to discern those firms
with the potential to continuously increase their sales and expand the market for their products from
those that may not have this potential or ability, and they react accordingly. Specifically, we show
that investors rely heavily on financial information provided by firms presenting a consistent
increase in sales since IPO. This is consistent with financial statements capturing the intensity of
assets-in-place (tangible assets) relative to future growth options (intangible assets) (Hand, 2005).
In contrast, for firms presenting stagnation or a consistent decrease in sales since IPO, financial data
is perceived by investors as not providing relevant, or predictive, information for investment
decision making.
An important inference of our findings is that, in effect, investors capture the ability of a
technology-based firm to continuously increase its sales as a signal for its potential to smoothly
transfer through the stages of the 'Technology Adoption Lifecycle' (Moore, 1999). According to
Moore, the market development of high-tech products has unique characteristics that require an
appropriate strategy, and the way to develop a high-tech market is by systematically progressing
from one group of consumers to another. Making the transition from an early market dominated by
a few visionary customers ('early adopters') to a mainstream market dominated by a large block of
customers ('early/late majority'') is the main obstacle facing high-technology firms, and is referred
to by Moore as 'crossing the chasm'. As a firm's success in making the transition from one segment
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of consumers to another will be directly expressed by an increase in its sales, investors are likely to
use a sales-based indicator to depict a firm's potential to cross the chasm embedded in the
technology adoption lifecycle. Hence, investors could perceive firms presenting a continuous
growth (non-growth or reduction) in sales as firms with(out) a potential to gain market majority. In
such a case, our results imply that investors' reliance on a firm's financial statements is affected by
the perceived ability of the firm to bridge the chasm and make the transition from early adopters to
majority.
Another inference of our results is that previous findings regarding the lack of valuerelevance of losses (e.g. Hayn, 1995) cannot be generalized across industries or subsectors. In our
setting, most growth firms still report losses; we show that the losses as well as the profits are
relevant to the valuation of these firms.
This paper contributes to the new innovative firm literature as well as to the accounting and
the entrepreneurial finance literature, by exploring growth and technology adoption effects on the
value-relevance of firms' financial information. These issues are of crucial importance to the hightech sector, particularly for start-up ventures. While the few value-relevance studies that focused on
the venture capital subsector (e.g. Armstrong, Davila, and Foster, 2006; Hand, 2005) relate changes
in the value-relevance of financial statements to a firm's maturity, as measured on the basis of time
(firm age), our findings indicate that the main factor affecting this value-relevance is a firm's ability
to continuously increase its sales and/or investors' perception of its ability to make the transition
through the stages of the technology adoption lifecycle. Furthermore, Hand's (2005) sample consists
only of biotech firms, whereas our sample includes firms in a broad range of industries.
The paper proceeds as follows: Section 1 reviews prior literature on the venture investment
industry in Israel and on the value-relevance of financial information. Section 2 discusses the
sample selection and the conceptual framework, and presents descriptive statistics. Section 3
presents the empirical results as well as a discussion of the results. Section 4 outlines conclusions
and practical implications.

1. Literature Review
A. The Venture Investment Industry in Israel
Previous studies have found that the emergence of the venture investment industry in Israel
is considered to be the most successful instance of diffusion of the Silicon Valley model of VC
outside of North America (Avnimelech and Teubal, 2004a, b; Bresnahan, Gambardella, and
Saxenian, 2001; Carmell and de Fontaenet, 2004). The portion of venture investments as a share of
GNP in Israel is the highest in the world (OECD 2003) – an average of 1.2 percent for the period
1997-2006 (Avnimelech and Teubal 2006), which is much higher than the averages for the US and
for EU countries in this period (Avnimelech and Schwartz, 2009; Schwartz and Bar-El, 2007;
NVCA and EVCA, 20072). Another important characteristic of the Israeli high-tech sector is the
relatively high portion of start-ups that went IPO. Israel is ranked among the leading countries with
the number of startups to go IPO in NASDAQ (Avnimelech and Teubal, 2006).
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B. Value-Relevance of Financial Statement Information
The extensive body of research on the value-relevance of financial statement information
indicates that GAAP are unsuitable for an economy that increasingly relies on science/technologybased industries. This is because these industries are characterized by large investments in
intangibles, such as R&D and intellectual capital, which are generally immediately expensed in
financial statements. Hence, reported earnings and book values are usually depressed, often
appearing unrelated to market values.
Studies on value-relevance of financial statement (accounting) information investigate the
association of equity prices or returns with a set of accounting data, where value-relevance is
defined as the information content (measured by the R-square ) of the examined data set. Findings
show that the value-relevance of financial statements has been consistently declining over the past
few decades (Brown, Lo, and Lys, 1999; Francis and Schipper, 1999; Lev and Zarowin, 1999).
Core, Guay, and Van Buskirk (2003) differentiate between high-tech and low-tech firms, and
document a decline in the relevance of financial accounting to equity valuation for both groups of
firms in the 'New Economy Period' (1996-1999).
Studies that focus on the high-tech sector yield mixed results. Hirschey, Richardson, and
Scholz (2001) for high-tech firms in general, and Hand (2003) for internet firms in particular, find
that both book value of equity and earnings are value-relevant. According to Core et al. (2003),
earnings are value-relevant while book value is not. Jorion and Talmor (2001) and Rajgopal,
Shevlin, and Venkatachalam (2003) find the opposite results for internet and e-commerce firms –
that book values (earnings) are (in)significantly associated with the market values of these firms.
Trueman, Wong, and Zhang (2001) show that earnings are not related to internet equity prices
(however gross profit is significantly positively related to these firms' equity prices). Amir and Lev
(1996) show that while neither earnings, cash flows, nor book value of equity are value-relevant for
the pricing of cellular firms, for biotechnology firms book values (earnings) are significantly
positively (negatively) related to market values. In contrast, Hand (2004) finds that earnings as well
as book values are significantly positively related to the market valuation of biotech firms. Callen,
Gavious, and Segal (2009) and Ely, Simko, and Thomas (2003) show that market values of biotech
firms are positively related to book values and R&D expenditures but not significantly related to
earnings before R&D. Hand (2005) compares the value-relevance of financial statements in the preIPO venture capital market for biotech firms and the post-IPO public equity market, and finds that
financial statements are value-relevant in both. In particular, financial statement data become even
more value-relevant as the firm matures, consistent with financial statements capturing the intensity
of assets-in-place relative to future growth options. Finally, Armstrong et al. (2006) show that
financial statement information is value-relevant in both the pre-IPO and post-IPO periods for a
sample of VC-backed firms from six different industries.
It has been demonstrated that when differentiating between earnings and losses, positive
(negative) earnings are found to be positively (negatively) related to market values. Core et al.
(2003) suggest that the negative coefficient on negative earnings indicates investors' expectations
that 'large losses precede higher future cash flows than small losses, possibly due to the transitory
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nature of large losses' (p. 56). Callen et al. (2009) explain that investors appear to be aware of
accounting deficiencies (such as the treatment of R&D as an expense rather than as an investment)
and are able to undo these deficiencies when they draw information from financial statements. The
negative coefficient on losses in firms operating in high-tech industries implies that investors can
'see through' the expensing of R&D and other investments in intangibles; the greater the losses, the
greater the market value.3
Concerns regarding the decline in the relevance of financial accounting to equity valuation
have also been expressed by the practitioner community. For example, in 1994 the American
Institution of Certified Public Accountants (AICPA) Committee on Financial Reporting (the
Jenkins Committee Report) called for the inclusion of important nonfinancial data in firms' financial
statements. Indeed, in recent years, international and US Financial Accounting Standard Boards
(FASB) have emphasized the recognition and measurement of various types of intangible assets in
financial statements.4 Notably, both international and US FASB are in the process of moving
towards fair-value accounting rather than historical-cost accounting (Benston, 2006).

2. Data, Measures and Methodology
The source of our start-up firm data is the Israel Venture Capital (IVC) Online database. The
IVC Online database is a comprehensive database on Israel's high-tech industry created by the
Israel Venture Capital Research Center. It includes information on Israeli high-tech companies,
venture capital and private equity funds, investment companies, professional service providers,
foreign investors, and technological incubators.
We extracted non-financial information from the IVC database including: year of IPO, firm
discipline, number and year of follow-on offerings, and number of employees at the time of IPO.
From the IVC database we also obtain information on share prices and total amount raised in IPOs
and seasoned equity offerings (SEOs). Because IVC database does not collect all the information
required for this study (particularly financial information), we collected market information – daily
share prices and NASDAQ index – from the Yahoo Finance database. Financial statement
information was obtained from the database of Yif'at Capital Disc Co. In order to fairly evaluate
financial statement information in our tests, we require the financial statements at the end of the
annual fiscal period. As our tests require us to calculate changes in certain annual measures, we
require not only the most recent annual financial statements but also the financial statements for the
prior year.
Our sample consists of 40 Israeli companies backed by VC investors that went IPO in
NASDAQ during 1993-2000. In all, 46 Israeli VC-backed companies went IPO in NASDAQ during
this period.5 We were not able to obtain sufficient data to estimate the variables used in our tests for
the six start-up ventures excluded from the analysis, as their entire outstanding shares were acquired
by other high-tech firms. For each of the 40 sample firms, financial and nonfinancial information
was gathered from the time of IPO up until 2004.
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We explore the sales record of each of our sample firms since IPO. For each firm, we
calculate the percentage change in annual sales in year t as ∆t = (St − St −1 ) / St −1 , where S t indicates
the total sales at year t. We identify two groups of firms. One group is composed of 21 firms that
presented a consistent increase in annual sales since the year of IPO (i.e. a positive

∆ t). Average

sales during the sample period (2001-2004) for this group were 173 percent higher than the sales in
the year of IPO, and the average (median) annual increase in sales was 25 percent (13 percent) (pvalue: 0.003 (0.001)). The other group (19 firms) consists of 17 firms that presented a consistent
decrease in annual sales since the year of IPO (a negative

∆ t in each year) and two firms with no

clear trend in sales. For this group, average sales for the sample period show a decrease of 40
percent from the year of IPO, and the average (median) annual decrease in sales was 6 percent (17
percent) [p-value: 0.099 (0.012)]. We henceforth refer to the two types of firms identified above as
continuous growth firms (CG firms) and non-growth firms (NG firms).
To test the robustness of our results to the proxy of growth, we repeat the analyses using a
market-value rather than a sales-based indicator (untabulated). In comparison to sales, market value
is not an accounting measure extracted from the firm's own financial statements; nonetheless, like
sales, it reflects a firm's growth potential. Notably, the results of the analyses are robust to
partitioning the sample on these alternative proxies.
We explore whether a continuous growth in sales can be attributed to a firm's maturity,
applying three variables typically used in the literature to indicate the maturity of start-up firms: (1)
number of years from IPO; (2) firm age; and (3) R&D expenditures per employee. The data indicate
that the number of years from IPO does not correlate with the change in sales since IPO, meaning
that a firm's rate of sales growth is not associated with the extent of time that passed since IPO.
Table 1, panel b shows that the distribution of year of IPO for the two groups of firms is quite
similar. Additionally, we find that both groups of firms are very close in age – the average number
of years from the date of incorporation for a CG firm is 14 and for a NG firm 13. Likewise, R&D
expenditure per employee does not differ significantly between CG and NG firms (average of $45
thousand and $53 thousand, respectively). The results do not change qualitatively when we compare
medians rather than averages. Hence, all indicators – number of years from IPO, firm age, and R&D
expenditures per employee – show that the (in)ability of CG (NG) firms to increase their sales
cannot be attributed to maturity.
The continuous increase (decrease) in sales in our CG (NG) firms also cannot be related to
industry-specific factors. Panel a in Table 1 shows that the distribution of firm discipline by NG and
CG firms is similar.
As the vast majority of our sample firms went public during the technology boom years
(second half of the 1990s; see Table 1, panel b), we restrict our analysis to the years that followed
the burst of the technology bubble, namely 2001-2004, resulting in 76 firm-years for NG firms and
84 firm-years for CG firms. This restriction ensures that we have full financial information for the
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entire sample period (12 out of the 40 firms in our sample went public in 2000). Additionally, this
restriction mitigates bubble market anomalies which otherwise might affect our analysis.

Table 1: Descriptive Statistics
The table provides descriptive statistics on the main financial and nonfinancial information items for our sample, by
Non-Growth ('NG') and Continuous Growth ('CG') firms. NG firms are firms presenting either a continuous reduction in
annual sales since IPO or no clear trend in sales. CG firms are firms presenting a continuous growth in sales since IPO.
In panels d.1 and d.2, SD is standard deviation. Market Value is based on market value of equity three months after
fiscal year-end. Book Value is book value of equity at fiscal year-end. Total Assets is total assets at fiscal year-end.
Goodwill and Other Intangible Assets are from the firm’s most recent annual financial statement. Sales is total
revenues; Sales_ch (percent) is percentage change in revenues from the preceding year. Earnings (CFO)-to-Price is the
ratio of earnings before extraordinary items (cash flows from operations) to market value. R&D-to-Sales and R&D-toAssets is R&D intensity measured as R&D expense divided by total revenues and total assets, respectively. Unscaled
financial data are measured in $millions. Extreme values (top and bottom 1 percent) of continuous variables are
winsorized.

Panel a: Distribution of Firm Discipline – percent

Communications, telecommunications, wireless communications
E-commerce, internet, software
Semiconductors, electronics
Medical devices, biotechnology
Miscellaneous technologies/hardware, printing
Total

NG
Firms

CG
Firms

39
44
6
11
0
100

29
48
10
10
5
100

Panel b: Distribution of Year of IPO (number of firms)

NG
Firms
CG
Firms

1993

1995

1996

1997

1998

1999

2000

Total

1

0

5

2

1

4

6

19

3

1

3

1

3

4

6

21

Panel c: Distribution of Follow-On Offerings – percent
Follow-on Offerings
0
1
2-3

NG Firms

CG Firms

33
50
17

19
33
48

8
The Journal of Entrepreneurial Finance Volume 13, Issue 2, Fall 2009
Total

100

100

Table 1 – continued
Panel d.1: Financial Data – NG Firms
Variable

Mean

Median

SD

Skewness

Kurtosis

Market Value

79

29

175

5.287

32.533

Book Value

33

16

47

4.160

23.001

Total Assets

47

29

56

3.010

12.334

Goodwill

1

0

5

3.936

15.100

Other Intangible Assets

0.2

0

0.6

3.137

8.675

Sales

17

11

23

3.463

14.794

Sales_ch ( percent)

-0.060

-0.172

0.927

4.500

24.677

Earnings-to-Price

-0.769

-0.235

2.051

-6.318

44.133

CFO-to-Price
R&D-to-Sales
R&D-to-Assets
Amount Raised at IPO
# Employees at Time of IPO
Amount Raised at IPO/ #
Employees

-0.439
1.383
0.237
36
164

-0.112
0.396
0.198
40
149

1.002
4.602
0.157
17
145

-3.781
6.976
1.592
-0.265
2.418

18.561
52.048
2.219
-0.799
6.154

0.308

0.258

0.195

1.323

1.209

Mean

Median

SD

Skewness

Kurtosis

Market Value

700

151

1,477

2.874

7.711

Book Value

177

86

303

3.384

12.057

Total Assets

298

117

472

2.627

6.136

Goodwill

24

0

66

4.422

21.037

Other Intangible Assets

6

0

10

2.181

4.551

118

58

147

2.087

3.778

Sales_ch ( percent)

0.248

0.127

0.768

4.425

24.747

Earnings-to-Price

-0.289

-0.013

1.424

-7.441

58.191

CFO-to-Price
R&D-to-Sales
R&D-to-Assets
Amount Raised at IPO
# Employees at Time of
IPO

-0.051
0.209
0.092
44

0.011
0.179
0.091
39

0.341
0.318
0.065
34

-3.723
0.623
-0.675
1.526

23.016
14.772
1.504
3.482

435

251

419

1.712

2.384

Panel d.2: Financial Data – CG Firms

Variable

Sales
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Amount Raised at IPO/ #
Employees

0.204

0.098

0.197

0.663

-1.078

Table 1 provides descriptive statistics on the major financial and non-financial information
items for the two groups of firms. The sample consists of start-up firms from various disciplines.
The distribution of firm discipline by NG and CG firms is presented in panel a. About half of the
IPOs for both NG and CG firms occurred in 1999-2000, the peak of the technology boom years
(Table 1, panel b). Nineteen percent of CG firms had no follow-on offerings compared with 33
percent of NG firms. On the other hand, almost 50 percent of CG firms had two or three follow-on
offerings compared with only 17 percent of NG firms (Table 1, panel c).
Panels d.1 and d.2 of Table 1 – for NG and CG firms, respectively – provide various
descriptive variables generally used in value-relevance studies on high-tech industries (see, e.g.
Amir and Lev 1996; Callen et al. 2009; Ely et al. 2003). The differences between NG and CG firms
are highly significant (at the 1 percent level) according to both parametric and non-parametric tests
for all financial variables. It is evident that CG firms are much larger than NG firms according to all
three size measures. Market value of CG firms is, on average, almost nine times the market value of
NG firms, and the book value of equity and total assets from the balance sheets of CG firms are
around six times that of NG firms.
Investments in intangible assets are also much larger in CG firms. For example, goodwill
amounts to $24 million in CG firms, on average, in comparison to only $1 million in NG firms
(notably, more than 75 percent of NG firms had no goodwill in their balance sheets), indicating that
the former were more active in corporate mergers and acquisitions. GAAP allow goodwill, as well
as other intangible assets, to be included in the balance sheet only when they are purchased. Thus,
the large investments in R&D and other intangibles such as customer-base, patents, and intellectual
capital, are largely expensed in financial statements and are not included as assets in the balance
sheet.
CG firms dominate NG firms also in the amounts of annual sales ($118 million compared
with $17 million on average, respectively). Whereas CG firms present an increase in annual sales
according to both mean and median (25 percent and 13 percent, respectively), NG firms' sales
decrease [-6 percent (-17 percent) on average (median)]. The ratios of Earnings-to-Price and Cash
Flows from Operations (CFO)-to-Price indicate that most NG firms report losses and negative cash
flows from operations (88 percent and 80 percent of the firm-year observations, respectively).
Although on average these ratios are also negative for CG firms, the frequency of firms with losses
and negative cash flows in this group is smaller (56 percent and 42 percent of the firm-year
observations, respectively). The depressed earnings and cash flows from operations in start-up firms
in general are consistent with the large intensity of R&D costs, which are, as stated, usually fully
expensed as incurred in accordance with accounting principles.6 It can be seen in Table 1 that R&D
intensity, taken either relative to sales (R&D-to-Sales) or to total assets (R&D-to-Assets), is much
higher for NG firms. This is not surprising, given the large costs of R&D and low revenues for most
NG firms. The higher intensity of R&D may be attributed to the efforts of NG firms to increase
their market penetration.
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Finally, the amount raised at IPO per employee is lower for CG firms [mean (median) $0.20
($0.10) millions] relative to NG firms [mean (median) $0.31 ($0.26) millions]. This may be
explained by CG firms naturally having more employees. Additionally, a relatively higher portion
of a CG firm's budget is gained through sales, and thus the amounts of money needed to be raised
from the public relative to the firm's size are lower in comparison to a NG firm.
3. Results
In our study we use both return analysis and price level analysis consistent with prior valuerelevance studies (e.g. Amir and Lev, 1996; Callen et al., 2009). Also consistent with the literature
(e.g. Collins et al., 1997; Hand, 2005), we run regressions of stock prices and returns on
combinations of financial statement data items, where we define value-relevance as the adjusted Rsquare from these regressions. In each regression analysis we mitigate the effects of outliers by
winsorizing observations in the top and bottom one percent of the dependent and independent
variables. We winsorize outliers instead of deleting them to conserve data. Results do not change
qualitatively when outliers are deleted. The regressions are estimated using panel data (the same
firms in successive years) with firm discipline and year fixed effects. Namely, we include intercept
dummies for each firm discipline and year to capture constant industry-specific and year-specific
factors.7 The regressions include White's (1980) correction. We conduct diagnose tests for our
regressions including collinearity diagnostics and residual diagnostics (e.g., VIF and DurbinWatson tests). The tests indicate that our regressions follow the standard conditions; i.e., we reject
the hypotheses (1) that multicollinearity exists between one independent variable and other
independent variable, (2) that a serial correlation of the residuals exists, and (3) that disturbances in
all regressions are not normally distributed.
A. Return Analysis
This section establishes the value-relevance of financial statement information in NG and
CG firms using narrow- and wide-window returns analyses. First, we examine the association of the
three- and seven-day abnormal returns centered on the annual earnings announcement date [CAR (1,1) and CAR (-3,3), respectively] with the level and change in earnings. Second, we examine the
association of annual returns with the level and change in earnings.8 Because GAAP-based earnings
are considered to be of limited value to investors in firms operating in fast changing, technologybased industries, we also run the same specifications with cash flows from operations (CFO) instead
of earnings consistent with prior studies (see, e.g. Amir and Lev, 1996).
The narrow return windows regressions are based on prior literature (e.g. Amir and Lev,
1996; Callen et al., 2009). Utilizing Easton and Harris's (1991) return version of the Ohlson (1995)
model, we run the following regression:

CARit = α 0 + α 1 E it + α 2 ∆E it + ε it

(1)
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where CAR is the size adjusted cumulative abnormal returns of firm i in the three or seven days
centered on the earnings announcement; E is the annual earnings per share (before extraordinary
items) deflated by the beginning of year price per share; and ∆E is the change in earnings per share
(before extraordinary items) from the previous year deflated by the beginning of year price per
share. As stated above, we run the same specification with CFO instead of E.9
The regressions results are presented in Table 2. Panel a shows that for NG firms both the
coefficients on the level and change in earnings are statistically insignificant in the three and sevenday return windows, as are the F-values (zero R-square). For CG firms, on the other hand, the
coefficients on earnings and the change in earnings are significant and positively related to
abnormal returns (according to both time windows). The same inferences are obtained when we
substitute cash flows from operations for earnings (displayed in panel b). From these results, it is
apparent that investors do not react either to earnings or to cash flows from operations reported by
NG firms, but they do react when reported by CG firms. When we compare between the
coefficients on cash flows and the coefficients on earnings we find that the former are significantly
larger for CG firms (p-value: 0.000). The difference in the magnitude of the coefficients indicates
that cash flows and earnings have different valuation characteristics for CG firms, i.e., current cash
flows from operations play a more important role as proxy for expectations about the future cash
flows of firms with an increasing level of product penetration.
Table 2: Regressions of Abnormal Returns Surrounding Earnings Announcements
The dependent variable is the cumulative abnormal return in the three and seven days centered on earnings
announcements. E (CFO) is annual earnings per-share before extraordinary items (cash flows from operating activities
per share) and

∆E

( ∆CFO ) is the change in E (CFO), both deflated by initial period price per share. The change in

earnings per share is computed as earnings minus the earnings reported in the preceding year. To mitigate the effect of
outliers, we winsorize the top and bottom 1 percent of the regression variables. P-values of the coefficients are
presented in parentheses. The regressions are estimated using panel data including industry- and year-fixed effects.

Panel a: Regressions on Earnings and Change in Earnings
NG Firms

Intercept
E

∆E
F-value
Adj_R2
N

CG Firms

CAR (-3,3)
-0.194
(0.134)
-0.041
(0.809)
0.010
(0.922)

CAR (-1,1)
-0.145
(0.208)
0.021
(0.889)
-0.036
(0.697)

CAR (-3,3)
0.016
(0.928)
2.062
(0.000)
0.959
(0.000)

CAR (-1,1)
0.011
(0.947)
2.085
(0.000)
0.972
(0.000)

0.634
(0.851)
0
76

0.425
(0.973)
0
76

19.644
(0.000)
0.68
84

20.370
(0.000)
0.69
84
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Panel b: Regressions on Cash Flows and Change in Cash Flows
NG Firms

Intercept
CFO

∆CFO
F-value
Adj_R2
N

CG Firms

CAR (-3,3)
-0.018
(0.880)
-0.145
(0.505)
0.021
(0.879)

CAR (-1,1)
0.000
(0.999)
-0.197
(0.304)
0.033
(0.782)

CAR (-3,3)
0.830
(0.025)
7.971
(0.000)
3.835
(0.000)

CAR (-1,1)
0.833
(0.026)
8.051
(0.000)
3.877
(0.000)

0.713
(0.779)
0
76

0.581
(0.892)
0
76

14.666
(0.000)
0.64
84

13.638
(0.000)
0.63
84

The annual return regression is formulated as:

Ann _ Rit = α 0 + α 1 E it + α 2 ∆E it + ε it

(2)

Ann_R is computed from nine months before fiscal year-end to three months after fiscal year-end.
The results of the annual regressions, presented in Table 3, are consistent with those obtained from
the narrow return window regressions. Whereas the coefficients on earnings (cash flows) and the
change in earnings (cash flows) are insignificant for NG firms, they are significantly positive for
CG firms at the 1 percent level. Again, for CG firms, the coefficients on the cash flow variables are
significantly larger than the coefficients on the earnings variables, indicating that cash flows are
more relevant for explaining equity values. The difference in the value implications of earnings and
cash flows is further pronounced in the sign differences of the coefficients on ∆E and ∆CFO in NG
firms. Specifically, NG firms have a lower coefficient on the change in earnings than CG firms,
however with the same positive sign. In contrast, when the change in cash flows is used, the
coefficient for NG firms becomes negative.
Additionally, for NG firms, the F-value as well as the R-square is significant only for the
annual return regressions and not for the narrow-window return regressions. We find that this
significance is due to the time and industry fixed effects. Excluding the fixed effects from NG firms'
annual returns regression on earnings variables, the F-value and adjusted R-square are 0.23 (pvalue: 0.795) and 0, respectively. Without the fixed effects the adjusted R-square of the annual
returns regression on cash flows variables is 0.02 and the F-value is 1.55 (p-value: 0.221).
The results thus far imply that financial statement information is highly value-relevant for
CG firms but value-irrelevant for NG firms. We contend that the difference in the valuation of
earnings in CG versus NG firms is not due to differences in the valuation of profits and losses

The valuation implications of sales growth in start-up ventures

13

documented in prior studies (e.g. Collins, Maydew, and Weiss, 1997; Collins, Pincus, and Xie,
1999; Hayn, 1995). Hayn (1995) shows that in regressions of annual returns on earnings, earnings
are virtually value-irrelevant for loss firms. Collins et al. (1997) and Collins et al. (1999) show
similar results for a regression of price on book value and earnings. Notably, CG and NG firms in
our study do not represent profit or loss firms, respectively. Although the frequency of loss firmyears within our sample of NG firms is naturally higher, most CG firms also report losses (an
average of -0.29 earnings-to-price ratio, see Table 1, panel d.2.). Thus, a 'permanent' versus
'transitory' earnings explanation is also irrelevant in this case, as CG firms cannot be considered as
generating permanent earnings. Our findings imply that for start-up firms with an increasing level
of product penetration, earnings are perceived as value-relevant even if these firms still do not
generate profits (i.e., even if the earnings are negative). These results suggest that prior findings
regarding the lack of value-relevance of losses cannot be generalized across industries or
subsectors, such as the VC subsector.
Table 3: Regressions of Annual Returns
The dependent variable is annual returns. It is computed from nine months prior to fiscal year-end to three months after
fiscal year-end. E (CFO) is annual earnings per-share before extraordinary items (cash flows from operating activities
per share) and

∆E

( ∆CFO ) is the change in E (CFO). The independent variables are deflated by the beginning of year

stock price. To mitigate the effect of outliers, we winsorize the top and bottom 1 percent of the regression variables. Pvalues of the coefficients are presented in parentheses. The regressions are estimated using panel data with industryand year-fixed effects.

Panel a: Regressions on Earnings and Change in Earnings

Intercept
E

∆E
F-value
Adj_R2
N

NG Firms

CG Firms

0.700
(0.545)
1.084
(0.489)
0.227
(0.810)

0.087
(0.947)
1.457
(0.000)
0.741
(0.007)

4.215
(0.000)
0.34
76

11.590
(0.000)
0.59
84
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Panel b: Regressions on Cash Flows and Change in Cash Flows

Intercept
CFO

∆CFO
F-value
Adj_R2
N

NG Firms

CG Firms

0.348
(0.763)
1.579
(0.446)
-0.362
(0.778)

-0.752
(0.439)
7.493
(0.000)
3.668
(0.003)

3.909
(0.000)
0.32
76

22.507
(0.000)
0.68
84

B. Level Analysis
The price regressions are based on a version of the Ohlson (1995) model:10

Pit = β 0 + β1 BVit + β 2 Eit + ε it

(3)

where P is the price per share three months after fiscal year-end, BV is the book value of equity per
share, and E is earnings per share before extraordinary items. We test the robustness of our results
to the scaling variable, using an additional, commonly used deflator – total assets – instead of total
shares outstanding (Easton and Sommers, 2002). Using total assets as a deflator results in inferences
throughout that are qualitatively the same.
Table 4, panel a presents the results for the price regression. As in the returns analysis, we
also present results for when earnings are replaced with cash flows from operations. Consistent with
the results obtained in the returns analysis, we find a strong relation between financial statement
information and stock prices in CG firms. The coefficients on book value, earnings, and cash flows
from operations are positive at the 1 percent level. The coefficient on cash flows from operations is
again significantly larger than the coefficient on earnings. When we allow positive and negative
earnings to have different slope coefficients, as well as different intercepts, we find no difference in
the valuation of profits and losses (the coefficient on negative earnings does not differ significantly
from the coefficient on positive earnings), indicating that the greater the earnings (losses), the
greater (lower) the market value. Prior studies that document negative coefficients on negative
earnings relate this finding to the extensive expensing of R&D as mandated by GAAP, which
artificially depresses earnings. For example, in the study of Callen et al. (2009), R&D expenditures
in a sample of drug development firms are, on average, 14 times their total sales. In this setting,
firms predominately report losses, however the market seems to be aware of the accounting
deficiencies and treats R&D as an investment rather than as an expense (see 'The Venture
Investment Industry in Israel' in the Literature Review). Our sample of CG firms, on the other hand,
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is not characterized by a high R&D intensity; rather, R&D expenditures are, on average, about 20
percent of total revenues. Thus, the market does seem to relate lower valuations to those firms that
are not able to generate positive profit margins from their sales, as these firms already dominate the
market majority.
Table 4: Price Regressions
The table shows the regression results of market value of equity on financial variables. The dependent variable is price
per share three months after fiscal year-end. BV is book value per share at fiscal year-end; E is annual earnings per
share before extraordinary items; CFO is cash flows from operating activities per share; TANG_ASS is tangible assets
per share; INTANG_ASS is intangible assets per share (including goodwill and other intangibles); TOT_LIAB is total
liabilities per share; R&D is research and development expenditures per share; E_R&D is annual earnings per share
before R&D and extraordinary items. To mitigate the effect of outliers, we winsorize the top and bottom 1 percent of
the regression variables. The regressions are estimated using panel data with industry- and year-fixed effects and
include White's (1980) correction. P-values of the coefficients are presented in parentheses.

Panel a: Price Regressions on Accounting Fundamentals

Intercept
BV
E
CFO
Adj_R2
F-value
N

NG Firms
10.638
37.746
(0.050)
(0.000)
-4.020
-5.799
(0.236)
(0.110)
-2.484
(0.120)
-2.740
(0.152)

CG Firms
1.637
4.567
(0.724)
(0.126)
1.726
0.956
(0.009)
(0.019)
1.758
(0.005)
2.033
(0.005)

0.22
2.426
(0.010)
76

0.63
15.863
(0.000)
84

0.22
2.383
(0.011)
76

0.61
14.338
(0.000)
84

Panel b: Price Regressions on Components of Financial Statements

Intercept
TANG_ASS
INTANG_ASS
TOT_LIAB
E_R&D
R&D

NG Firms
-7.016
(0.108)
-0.549
(0.875)
-1.246
(0.888)
9.727
(0.010)
-2.605
(0.146)
-0.039

CG Firms
-1.261
(0.868)
2.080
(0.008)
-0.305
(0.874)
-0.925
(0.337)
1.546
(0.016)
0.543
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Adj_R2
F-value
N

(0.995)

(0.095)

0.37
4.511
(0.000)
76

0.65
15.515
(0.000)
84

In contrast to CG firms, the coefficients on all three accounting fundamentals are unusually
negative and insignificant for NG firms (the coefficient on cash flows from operations is more
negative than the coefficient on earnings). The insignificant, counter-intuitive coefficients combined
with the evidence from the returns analyses cast doubt on the usefulness and relevance of financial
statements for the pricing of NG firms' securities. The relatively large adjusted R-square (0.22) and
significant F-values in the regressions for NG firms are again due to time and industry fixed effects.
Without these effects, adjusted R-square and F-value for the regression on book value and earnings
(cash flows) are 0 and 0.883, p-value: 0.419 (0 and 1.025, p-value: 0.366). It seems that financial
statements contain less information with respect to the value of start-up firms that fail to increase
their sales subsequent to the IPO, or what is more, suffer from a continuous reduction in sales in
comparison to firms that continuously increase sales. Hence, the variation in the values of NG firms
remains to be explained by other explanatory variables which are omitted from regression (3), and
are probably not correlated with the explanatory financial statement variables. Markedly, whereas
the market value of CG firms comprises a larger portion of the present value of growth
opportunities relative to the value of assets-in-place, and while these growth opportunities are best
regarded as risky call options to make future investments (Myers, 1977), conservative accounting
information is still more value relevant for CG firms than it is for NG firms.
We repeat the return and level analyses by adding to the regression firm age and R&D
expenditure per employee to capture firms' maturity. Both variables have insignificant coefficients
in all regressions, and the results remain qualitatively the same. Additionally, we apply a pooled
sample specification in which each of the explanatory variables is also interacted with firm age. We
find that the coefficients on these interactive variables are insignificantly different from zero. This
further emphasizes that investors in start-up firms are, in fact, affected by a firm's proven ability to
continuously increase its market penetration, rather than by other conventional indicators of a firm's
maturity, such as age.11 Once the ability of the firm to consistently increase sales is accounted for,
these other indicators do not have an incremental affect on an investor's reaction to the firm's
financial information. Finally, we repeat the return and level analyses, where we employ tests of the
joint sample of CG and NG firms, with a sales growth dummy. The inferences are similar and as
robust as those reported.
Upon regressing prices on financial variables, we also decompose book value of equity and
earnings into their major components.12 Book value of equity is decomposed into tangible assets
(TANG_ASS), intangible assets (INTANG_ASS), and total liabilities (TOT_LIAB). Earnings are
decomposed into research and development expenditures (R&D) and earnings before research and
development expenditures (E_R&D), consistent with prior research on high-technology, sciencebased industries (e.g. Amir and Lev, 1996; Callen et al., 2009; Ely et al., 2003). Table 4, panel b
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displays the regressions results. For CG firms, we find that tangible assets, earnings before R&D,
and the level of R&D expenditures are significantly positively related to stock prices. The positive
coefficients on R&D and earnings before R&D are consistent with the literature on R&D valuation
(e.g. Amir and Lev, 1996; Bowen and Shores, 2000; Callen et al., 2009; Chambers, Jennings, and
Thompson, 1998; Ely et al., 2003; Hand, 2005; Lev and Sougiannis, 1996; Shortridge, 2000). Ely et
al. (2003) find that earnings before R&D are significant and positively related to market value only
for biotech firms that have approved drugs, i.e. firms that generate revenues and are beyond the
development stage. For a sample of drug development firms (i.e. firms that are still in the
development stage), Callen et al. (2009) indeed find that the coefficient on earnings before R&D is
positive but not significantly different from zero. Equivalent to these findings, the coefficient on
earnings before R&D is significantly positive for our sample of start-up firms that have succeeded
to generate continuously increasing revenues since IPO. The insignificant, nonsensical (negative)
sign of the coefficient on intangible assets is not surprising. Although the intrinsic value of
technology-based firms derives mainly from intangible assets, these are usually not fairly
represented in the balance sheet as they are either immediately expensed or arbitrarily amortized
(see, e.g. Amir and Lev, 1996). The undervaluation of intangible assets in the balance sheets of our
sample firms is reported in Table 1, panels d.1 and d.2. These balance-sheet items are of dubious
relevance to the pricing of start-up firms in general. Tangible assets, on the other hand, are found to
be highly significantly related to the pricing of CG firms. Hand (2005) shows that as the firm
matures, financial statement information becomes more value-relevant. He explains that this is
consistent with financial statements capturing the intensity of on-balance-sheet assets-in-place
(tangible assets) relative to future investment options (intangible assets). When we separate tangible
assets into cash and non-cash assets, we find that the coefficients on both are positive and
significant at the 1 percent level. The coefficient on total liabilities is, as expected, negative though
insignificant (see also Hand, 2005).
For NG firms the coefficients on tangible assets, intangible assets, R&D, and earnings
before R&D all have counter-intuitively negative signs and are statistically insignificant, while the
coefficient on total liabilities is significantly positive. When we run the regression without year- and
industry-fixed effects, the regression remains significant at the 1 percent level with an adjusted Rsquare of 19 percent. The only significant coefficient remaining is that of total liabilities (7.018, pvalue: 0.000). A possible explanation for the positive relation between the liabilities of NG firms
and market values is that these liabilities are positively correlated with what the market conceives as
these firms' potential to survive. The market searches for indicators for the potential of such firms to
increase their market penetration, that is, to develop a continuously growing market for their
products. The liabilities indicate that the NG firm was able to get creditors to invest in it. This
ability may indirectly serve as a positive signal to investors, since more liabilities imply that
creditors believe in the firm, or at least are willing to take the risk of doing business with it.
C. Discussion: The Moore 'Technology Adoption Lifecycle' Model
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Our findings indicate that investors are able to discern those firms with the potential to
continuously increase their sales and expand the market for their products from those that may not
have this potential or ability, and then react accordingly.
In his book Crossing the Chasm, Moore (1999) deals with the market development of hightech products and presents a 'Technology Adoption Life Cycle' model. According to Moore, the
way to develop a high-tech market is by systematically progressing from one group of consumers to
another, 'focusing first on the innovators, growing that market, then moving on to the early
adopters, growing that market, and so on, to the early majority, late majority, and even to the
laggards' (p.14). These groups are distinguished by their characteristic response to a new,
discontinuous innovation based on a new technology. Each group represents a different
psychographic group that is composed of a combination of psychological and demographic
profiles.13 Different psychographic profiles imply that when purchasing a product, different groups
have different considerations. In other words, the group has a difficult time accepting a new product
if it is marketed in the same way as it was marketed to the previous group. This lack of continuity in
each transition from one group to another bears with it an inherent risk of the marketing losing its
momentum, hence missing the transition to the next group of consumers and possibly missing out
on a large market where the real profit is (obviously, the main goal is to gain profit-margin
leadership).14
In the model, a gap is introduced between each two groups. The gaps reflect the lack of
continuity in the transition from one group to another. Moore (1999) distinguishes between two
types of gaps: a crack and a chasm. A crack is considered the less significant of the two, and there
are three of these across the curve. The first is between the innovators and the early adopters, the
second falls between the early majority and the late majority, and the third is between late majority
and the laggards. The chasm is more substantial, in that it separates the early adopters from the
early majority. Moore explains that the transition from early adopters to early majority is the most
difficult, and as it typically goes unrecognized the risk of falling into the chasm is extremely high.
Markedly, while the marginal investor in the market can easily track a firm's sales,
identifying its exact stage in the technology adoption lifecycle is not straightforward. As a firm's
success in making the transition from one segment of consumers to another should be directly
expressed by an increase in its sales, the market is likely to use a sales-based indicator to capture a
firm's potential to bridge the gaps embedded in the technology adoption lifecycle. Hence, a possible
inference of our findings is that investors, in effect, denote a firm's ability to continuously increase
its sales as a signal for its ability to cross the chasm and make the transition from an early market
dominated by a few visionary customers to a mainstream market. In contrast, a firm with
continuously decreasing sales (or lacking a positive trend in sales) may not succeed in making this
transition, and is more likely to be 'stuck' in the early adopters segment. Our findings, therefore,
may indicate that investors' reliance on a firm's financial statements is affected by the perceived
ability of the firm to cross the chasm. Indeed, the transition from early adopters to majority
indicates a conversion of future growth options into assets-in-place, and thus financial statement
information should be more relevant for the pricing of market majority firms. On the other hand,
firms in the stage of early adopters may have greater future growth options ('positive intangibles')

The valuation implications of sales growth in start-up ventures

19

which are not represented in their financial statements, or they may fall into the chasm – a risk that
is also not represented in financial statements ('negative intangibles'). Neither the opportunities nor
the risks are represented in their financial statements. The high degree of uncertainty with regard to
the future prospects of these firms leads to investor skepticism as to the reliability or relevance of
their financial statements.

4. Summary and Concluding Remarks
We examine whether and how investors' reliance on financial information is affected by the
sales growth of a start-up venture. We find that investors seem to be able to discern those firms with
the potential to continuously increase their sales and expand the market for their products from
those firms that may not have this potential or ability, and they react accordingly. For the latter,
financial data are perceived by investors as not providing relevant, or predictive, information for
investment decision making. In contrast, the results show that investors rely heavily on financial
statement information provided by continuously growing firms, consistent with the fact that
financial statements capture the intensity of assets-in-place relative to potential growth options.
Once the ability of the firm to continuously increase its sales is accounted for, other indicators used
in prior studies to capture a firm's maturity (e.g. firm age) do not have an incremental affect on an
investor's reaction to the firm's financial information. We conclude that changes in the valuerelevance of financial statements of science-based, fast growing firms are related to the degree of
these firms' market penetration rather than to their maturity as measured on the basis of time.
We suggest that investors may interpret a firm's ability to continuously increase its sales as
an ability to transfer through the stages of the technology adoption lifecycle. In such a case, our
results imply that investors' reliance on a firm's financial statements is affected by its perceived
ability to bridge the chasm embedded in the technology adoption lifecycle and to make the
transition from early adopters to a mainstream market. An important implication of this inference is
that young high-tech firms should not be evaluated before their stage in the technology adoption life
cycle is identified. The firm's stage in the technology adoption life cycle can have an acute
influence on the data that constitutes a base for evaluation, and thus, on the most appropriate
methodology for evaluation. Should the accounting data be irrelevant for firm valuation, analysts
and investors need to identify which off-balance-sheet data are value-relevant for the specific firm.
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Notes
1

See, for example, Armario, Ruiz, and Armario (2008); Hering, Olbrich, and Steinrucke (2006).

2

NVCA – National Venture Capital Association (www.nvca.org)
EVCA – European Venture Capital Association (www.evca.com)

3

Some of these studies also examine the value-relevance of nonfinancial information and the relationship between

financial and nonfinancial information in explaining stock pricing (e.g. Amir and Lev, 1996; Callen et al., 2009; Ely et
al., 2003; Hand, 2005). The examination of nonfinancial information is possible when focusing on a specific firm
discipline within the high-tech sector (e.g. telecommunications, biotechnology, e-commerce) because each discipline is
characterized by different value-relevant nonfinancial data [i.e. nonfinancial information is typically discipline/industryspecific; for example, drug development stage for biotech firms, market penetration (number of subscribers) for cellular
firms, etc.]. Our study, on the other hand, is based on start-up firms from various disciplines which make an
investigation of the value-relevance of nonfinancial information impractical. See also, Amir and Lev (1996, p.6).
4

For example, International Financial Reporting Standard No. 3 (IFRS 3), 2004, Business Combinations.

5

The list of companies was drawn from the Israel Venture Capital (IVC) Online database. Various sampling procedures

employed resulted in smaller samples which have yielded similar qualitative results as those presented in the paper.
However employing smaller samples reduced the robustness of the statistical tests. We thus choose to use all of the
available data.
6

FASB Statement No. 2: Accounting for Research and Development Costs.

7

We also run the regressions without the fixed effects. Inferences remain qualitatively the same.

8

Callen et al. (2009) also employ annual returns regressions in addition to narrow return windows regressions.

9

As the change in earnings - not the level of earnings - drive returns (the latter is used in the return regressions as a

control variable), we conduct a sensitivity analysis where we run regressions including only the change in earnings (or
cash flows). Inferences remain the same as those reported in the tables.
10

This price regression specification is commonly used to examine the relation between price and the two summary

financial statement measures, book value of equity and earnings.
11

We point out that the findings documented in this study may not be interpreted as indicative of established, mature

firms simply having accounting fundamentals that are more descriptive of investors' future expectations. In particular,
NG and CG firms in our sample do not differ significantly either in age or in the number of years from IPO.
Additionally, as shown above, most CG as well as NG firms still report losses.
12

According to Hand (2005), the use of major components of the aggregate book value of equity and net income helps

to avoid 'the severe inferential distortions that can arise when evaluating the value relevance of financial statements of
fast growing, highly intangible-intensive companies' (Hand, 2004; Zhang, 2001).
13

For the definition and specific characteristics of each segment, see Moore (1999, pp.9-13).

14

Branscomb and Auerswald (2001) explain that operating risks of technology-based emerging industries may be

measured by the probability that the firm will not meet its sales forecasts.
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